Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 South & Central America Molecular Diagnostic for Infectious Diseases Market, by Country, Market attractiveness

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics

4.1 Market Drivers:

4.1.1 Surging Prevalence of Infectious Disease Globally

4.1.2 Rising Application of Molecular Diagnostics in Veterinary Infectious Diseases

4.2 Market Restraints

4.2.1 Limitations Associated with Molecular Testing

4.3 Market Opportunities

4.3.1 Advancements in Molecular Diagnostics Technologies

4.4 Future Trends

4.4.1 Molecular Diagnostics for Infectious Diseases in Personalized Medicine

4.5 Impact Analysis:

5. Molecular Diagnostic for Infectious Diseases Market - South & Central America Market Analysis

5.1 South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Type

6.1 Overview

6.2 South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue Share, by Type, 2022 & 2030 (%)

6.3 Point-of-Care Testing

6.3.1 Overview

6.3.2 Point-of-Care Testing: South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Laboratory Testing

6.4.1 Overview

6.4.2 Laboratory Testing: South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by End User

7.1 Overview

7.2 South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing and Laboratory Testing by End User, 2022 & 2030 (%)

7.2.1 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)

7.2.2 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

8. South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Application

8.1 Overview

8.2 Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Application, 2022 & 2030 (%)

8.3 Point-of-Care Testing

8.3.1 Overview

8.3.2 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)

8.4 Laboratory Testing

8.4.1 Overview

8.4.2 South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

9. South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Disease Type

9.1 Overview

9.2 South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Disease Type, 2022 & 2030 (%)

9.3 Point-of-Care Testing

9.3.1 Overview

9.3.2 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)

9.3.2.1 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)

9.4 Laboratory Testing

9.4.1 Overview

9.4.2 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)

9.4.2.1 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

10. South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Infection Type

10.1 Overview

10.2 South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Infection Type, 2022 & 2030 (%)

10.3 Point-of-Care Testing

10.3.1 Overview

10.3.2 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)

10.4 Laboratory Testing

10.4.1 Overview

10.4.2 South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

11. South & Central America Molecular Diagnostic for Infectious Diseases Market - Country Analysis

11.1 South & Central America Molecular Diagnostic for Infectious Diseases Market, Revenue and Forecast to 2030

11.1.1 South & Central America Molecular Diagnostic for Infectious Diseases Market, by Country

11.1.1.1 Brazil

11.1.1.1.1 Brazil Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.1.2 Brazil: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)

11.1.1.1.3 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)

11.1.1.1.4 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

11.1.1.1.5 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)

11.1.1.1.6 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

11.1.1.1.7 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.1.7.1 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)

11.1.1.1.8 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.1.8.1 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

11.1.1.1.9 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.1.10 Brazil: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.2 Rest of South & Central America

11.1.1.2.1 Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)

11.1.1.2.3 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)

11.1.1.2.4 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

11.1.1.2.5 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)

11.1.1.2.6 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

11.1.1.2.7 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.2.7.1 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)

11.1.1.2.8 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)

11.1.1.2.8.1 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

11.1.1.2.9 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)

11.1.1.2.10 Rest of South & Central America: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Abbott Laboratories

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Thermo Fisher Scientific Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 bioMerieux SA

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Danaher Corp

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Hologic Inc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens Healthineers AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Bruker Corp

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 DiaSorin SpA

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

List of Tables

Table 1. South & Central America Molecular Diagnostic for Infectious Diseases Market Segmentation

Table 2. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point of Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 3. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 4. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 5. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 6. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 7. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)

Table 8. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 9. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)

Table 10. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 11. South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 12. Brazil Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)

Table 13. Brazil Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Brazil Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 15. Brazil Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. Brazil Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 17. Brazil Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 18. Brazil Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)

Table 19. Brazil Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 20. Brazil Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)

Table 21. Brazil Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 22. Brazil Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 23. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)

Table 24. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 25. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)

Table 26. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 27. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)

Table 28. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 29. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)

Table 30. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)

Table 31. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)

Table 32. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 33. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)

Table 34. Organic Developments Done By Companies

Table 35. Inorganic Developments Done By Companies

Table 36. Glossary of Terms, Molecular Diagnostic for Infectious Diseases Market

List of Figures

Figure 1. South & Central America Molecular Diagnostic for Infectious Diseases Market Segmentation, By Country

Figure 2. South & Central America Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue (US$ Mn), 2022 - 2030

Figure 5. South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue Share, by Type, 2022 & 2030 (%)

Figure 6. Point-of-Testing: South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Laboratory Testing: South & Central America Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing and Laboratory Testing by End User, 2022 & 2030 (%)

Figure 9. Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Application, 2022 & 2030 (%)

Figure 10. South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Disease Type, 2022 & 2030 (%)

Figure 11. South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Infection Type, 2022 & 2030 (%)

Figure 12. South & Central America Molecular Diagnostic for Infectious Diseases Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 13. South & Central America Molecular Diagnostic for Infectious Diseases Market, By Key Countries, 2022 and 2030 (%)

Figure 14. Brazil Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

Figure 15. Rest of South & Central America Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)

Figure 16. Growth Strategies Done by the Companies in the Market, (%)